Pulse Biosciences Inc. (PLSE)
NASDAQ: PLSE
· Real-Time Price · USD
16.17
-1.14 (-6.59%)
At close: Aug 15, 2025, 3:59 PM
16.48
1.92%
After-hours: Aug 15, 2025, 07:20 PM EDT
Pulse Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -19.17M | -16.8M | -19.39M | -12.68M | -11.38M | -10.14M | -11.93M | -10.57M | -9.91M | -9.8M | -9.2M | -18.04M | -14M | -17.27M | -15.42M | -14.28M | -15.32M | -18.64M |
Depreciation & Amortization | 273K | 283K | 287K | 294K | 298K | 299K | 304K | 299K | 302K | 302K | 336K | 339K | 354K | 326K | 297K | 287K | 282K | 280K |
Stock-Based Compensation | 5.19M | 5.68M | 6.79M | 2.98M | 2.05M | 1.76M | 3.34M | 1.8M | 1.14M | 896K | 748K | 723K | 1.71M | 2.01M | 3.61M | 1.58M | 2.45M | 6.96M |
Other Working Capital | n/a | -3.37M | 3.12M | 284K | 790K | -1.57M | 1.06M | -1.63M | -362K | 1.45M | -383K | -815K | 1.02M | 360K | 161K | 724K | -2.83M | 396K |
Other Non-Cash Items | 899K | n/a | 6K | n/a | n/a | n/a | 3.54M | 2.73M | -1.71M | 914K | 1.29M | 7.37M | 4.34M | 3.71M | -6.2M | 3.85M | 3.97M | 13K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -3.52M | -2.73M | 1.71M | -914K | n/a | n/a | -4.34M | n/a | 6.2M | n/a | n/a | n/a |
Change in Working Capital | n/a | -2.69M | 3.15M | 380K | 638K | -1.7M | 1.49M | -2.02M | -737K | 2.03M | -1.14M | -1.03M | -893K | -654K | -1.19M | -932K | -3.77M | -306K |
Operating Cash Flow | -12.81M | -13.52M | -9.14M | -9.02M | -8.39M | -9.78M | -6.78M | -10.49M | -9.2M | -6.57M | -7.96M | -10.63M | -12.82M | -15.59M | -12.69M | -13.35M | -16.37M | -11.69M |
Capital Expenditures | -103K | -45K | -53K | -38K | -29K | -5K | -43K | -23K | -16K | -39K | -41K | -62K | -19K | -279K | -134K | -157K | -95K | -51K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8M |
Other Investing Acitivies | -20K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8M |
Investing Cash Flow | -123K | -45K | -53K | -38K | -29K | -5K | -43K | -23K | -16K | -39K | -41K | -62K | -19K | -279K | -134K | -157K | -95K | 7.95M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.75M | -828K | -917K | n/a | 65M | n/a | n/a | -657K | n/a | n/a | 41M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -17K | n/a | n/a | 372K | 810K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -55.1M | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 48.5M | n/a | n/a | 9K | n/a | -1K | 14.7M | 194K | n/a | 58K | n/a | -437K | 108K | 8.07M | -39.45M | 10.16M |
Financial Cash Flow | n/a | 14.81M | 48.2M | 61.9M | -265K | 305K | 804K | 2.15M | 13.87M | -432K | -17K | 65.06M | 14.96M | -65K | -549K | 8.07M | 4M | 51.16M |
Net Cash Flow | -12.93M | 1.24M | 39.01M | 52.84M | -8.69M | -9.48M | -6.02M | -8.36M | 4.65M | -7.04M | -8.02M | 54.36M | 2.12M | -15.94M | -13.38M | -5.43M | -12.46M | 47.42M |
Free Cash Flow | -12.91M | -13.57M | -9.2M | -9.06M | -8.42M | -9.79M | -6.82M | -10.51M | -9.22M | -6.61M | -8.01M | -10.69M | -12.84M | -15.87M | -12.83M | -13.51M | -16.46M | -11.74M |